跳至主要内容
临床试验/CTRI/2019/06/019629
CTRI/2019/06/019629尚未招募未知

eutrophil-lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) as predictive markers for chronic kidney disease in persons with type 2 diabetes

Dr Vignesh Kumar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Persons with type 2 diabetes without nephropathy or other complications
  • 2. Persons with type 2 diabetes with CKD

排除标准

  • 1. Patients having low glomerular filtration rate (GFR) without microalbuminuria will be excluded from the study.
  • 2. Patients with type 1 DM
  • 3. Febrile patients/patients with infections including urinary tract infection (UTI), respiratory tract infections, gastrointestinal infection, otitis media, viral hepatitis, parasitic infection, viral infection, tuberculosis, local infection, skin infection, AIDS, pyrexia of unknown origin, and any other infectious disease.
  • 4. Patients with systemic disorder such as cardiovascular disease, chronic liver disease, blood disorders, autoimmune disorders, malignancy, poisoning;
  • 5. Patients on anti-inflammatory drugs, systemic or topical steroids, alcohol;
  • 6. Patients with uncontrolled blood pressure (BP);
  • 7. Patients having diseases affecting urinary protein excretion as nephritic syndrome, urolithiasis, renal insufficiency, renal artery stenosis, dehydration state, and UTI

研究者

发起方
Dr Vignesh Kumar

相似试验